股市必读：东诚药业（002675）8月6日主力资金净流入3321.51万元

Summary of Key Points Core Viewpoint - Dongcheng Pharmaceutical (002675) has shown a positive trading performance with a closing price of 18.15 yuan, reflecting a 3.77% increase on August 6, 2025, alongside significant capital inflow from major investors [1]. Trading Information Summary - On August 6, 2025, Dongcheng Pharmaceutical experienced a net capital inflow of 33.21 million yuan from major investors, while retail investors saw a net outflow of 13.22 million yuan [1][3]. Company Announcement Summary - Dongcheng Pharmaceutical announced a guarantee contract with Industrial and Commercial Bank of China for a loan of 150 million yuan for its subsidiary, Yantai Dongcheng Dingnuo Biopharmaceutical Co., Ltd. This brings the total guarantee amount to 526.12 million yuan [1][3]. - The total guarantee amount provided by the company for its subsidiaries is now 526.12 million yuan, which represents 23.31% of the company's audited net assets for 2024 [1]. - The company has not provided guarantees for any entities outside its controlling subsidiaries, and there are no overdue guarantees or litigation issues related to these guarantees [1].